





BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.4.12//EN
TZID:Europe/Helsinki
X-WR-TIMEZONE:Europe/Helsinki
BEGIN:VEVENT
UID:187039@bioscience.fi
DTSTART;TZID=Europe/Helsinki:20261210T120000
DTEND;TZID=Europe/Helsinki:20261210T140000
DTSTAMP:20261104T113537Z
URL:https://bioscience.fi/events/frontiers-of-science-prof-thomas-helleday
 /
SUMMARY:Frontiers of Science and LUNCH: Prof. Thomas Helleday
DESCRIPTION:10th December at 12:00 and free lunch at 13:00\nOnsite event\ni
 n Presidentti auditorium\, BioCity\nAutumn 2026 poster\n\nProf. Thomas Hel
 leday\, Karolinska Institutet\, Sweden\nTargeting cancer by oncogenic trap
 ping: From bench to clinical trials\n\nHost: Jukka Westermarck (jukka.west
 ermarck@utu.fi)\n\nNo coffees nor sandwiches\, but lunch for 150 first one
 s to sign up\, right after the FoS talk\, in BioCity lobby\, as a thank yo
 u for being active members of BioCity Turku. Everyone is welcome to join\,
  register here: https://link.webropolsurveys.com/S/D6C3D85639FBE114\n\nSix
  PhD researchers and early-career postdocs are welcome to share a lunch ta
 ble and discuss with Prof. Helleday after the seminar. This is a great pos
 sibility to learn hosting skills in a friendly environment and create conn
 ections for future. If you got interested\, please send an email to biocit
 yturku@bioscience.fi\n\n&nbsp\;\n\nThomas Helleday is a Professor of Chemi
 cal Biology in Karolinska Institutet\, Sweden. In his research\, he is foc
 using on exploiting the weaknesses of cancer cells in DNA repair and alter
 ed metabolism. His research group uses genetic tools and develops probes t
 o study identified target proteins more closely. By selectively inhibiting
  DNA repair or proteins that are crucial for the growth of cancer cells\, 
 the researchers tailor new treatment methods against cancer.\n\n&nbsp\;\n\
 nSelected publications\n\nMortusewicz O\, Haslam J\, Gad H\, Helleday T. U
 racil-induced replication stress drives mutations\, genome instability\, a
 nti-cancer treatment efficacy\, and resistance. Mol Cell. 2025 May 15\;85(
 10):1897-1906\n\nGreen AC\, Marttila P\, Kiweler N\, …\, Sandberg L\, Fr
 ödin M\, Moussay E\, Slipicevic A\, Letellier E\, Paggetti J\, Sørensen 
 CS\, Helleday T\, Henriksson M\, Meiser J. Formate overflow drives toxic f
 olate trapping in MTHFD1 inhibited cancer cells. Nat Metab. 2023 Apr\;5(4)
 :642-659.\n\nMarklund M\, Schultz N\, Friedrich S\, Berglund E\, Tarish F\
 , Tanoglidi A\, Liu Y\, Bergenstråhle L\, Erickson A\, Helleday T\, Lamb 
 AD\, Sonnhammer E\, Lundeberg J. Spatio-temporal analysis of prostate tumo
 rs in situ suggests pre-existence of treatment-resistant clones. Nat Commu
 n. 2022 Sep 17\;13(1):5475\n\nMichel M\, Benítez-Buelga C\, Calvo PA\, 
 …\, Vilotijevic I\, Kalderén C\, Osorio A\, Perona R\, Stolz A\, Stenma
 rk P\, Berglund UW\, de Vega M\, Helleday T. Small-molecule activation of 
 OGG1 increases oxidative DNA damage repair by gaining a new function. Scie
 nce. 2022 Jun 24\;376(6600):1471-1476\n\n&nbsp\;\n\nGeneral information\n\
 n 	Registration is not needed\, participation list is circulated in the au
 dience.\n 	If you are a student and later wish to get a certificate of att
 endance from the Frontier of Science seminars (BKEM1020\; UTU)\, print out
  the seminar diary and after the seminar ask the BioCity coordinator to si
 gn it https://seafile.utu.fi/d/44a70f80ac1e46a9ad0a/\n 	Please note that a
 ny audio or video recording of the seminars is strictly forbidden.\n 	Autu
 mn 2026 image credits to Samuel Svärd: Whole mount immunofluorescent stai
 ning of the mouse retina. Image acquired on 3i CSU-W1 Spinning disk with 1
 0x objective.\n\n&nbsp\;
ATTACH;FMTTYPE=image/jpeg:https://bioscience.fi/wp-content/uploads/2026/09
 /helleday-thumbnail.jpg
CATEGORIES:Turku Bioscience Events
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
X-LIC-LOCATION:Europe/Helsinki
BEGIN:STANDARD
DTSTART:20261025T030000
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
END:STANDARD
END:VTIMEZONE
END:VCALENDAR